StayClued

Venrock

Undisclosed; no standardized first-check range is published in the reviewed sources. · seed, series-a, series-b, growth · US and Global selectively

Long-running US venture firm investing early in technology and healthcare, alongside a separate later-stage healthcare program.

Tier 2 · ranked #148biohealth

Visit / pitchOfficial siteOpen in the live directory

Key facts

Fund sizeCurrent comparable vehicle size is not disclosed in the reviewed sources
Stageseed, series-a, series-b, growth
Typical first checkUndisclosed; no standardized first-check range is published in the reviewed sources.
Sectorshealthcare, biotechnology, enterprise, ai, fintech, defense
GeographyUS and Global selectively
Statusopen

Always confirm on the official page before applying — dates and terms change.

Background

Long-running US venture firm investing early in technology and healthcare, alongside a separate later-stage healthcare program. The reviewed sources distinguish disclosed facts from comparable economics that remain private.

How the application really works

No dedicated public pitch route was confirmed. Use the official team page to identify a relevant investor and seek a trusted introduction without inferring private contact details.

Tips

Watch out for

Track record

No comparable acceptance or investment-rate statistic is published.

Investment thesis

Back early healthcare and technology companies with domain-specialist partners and long-duration support.

How to reach them

Notable portfolio

AppleIntelGileadDollar Shave ClubCloudflare

Frequently asked questions

What stage does the firm invest at?
seed, series-a, series-b, growth
What is the latest disclosed fund or capital base?
Current comparable vehicle size is not disclosed in the reviewed sources.
What check size does it write?
Undisclosed; no standardized first-check range is published in the reviewed sources.
Where does it invest?
US and Global selectively
How can a founder approach the firm?
No dedicated public pitch route was confirmed. Use the official team page to identify a relevant investor and seek a trusted introduction without inferring private contact details.
What remains undisclosed?
Comparable check range, ownership target, reserves allocation, decision speed and a universal board policy remain undisclosed unless explicitly stated above.

Related venture funds

AdditionNot publicly disclosed in the reviewed sources. · GlobalVariantUndisclosed; no standardized first-check range is published in the reviewed sources. · GlobalInsignia Ventures PartnersUndisclosed. · Southeast AsiaUpfront VenturesNot publicly disclosed in the reviewed sources. · USPolychain CapitalNot publicly disclosed in the reviewed sources. · GlobalUnusual VenturesNot publicly disclosed in the reviewed sources. · US

Sources